Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy

E-ISSN： 1875-5968|5|3|267-279

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.5, Iss.3, 2005-05, pp. : 267-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 4, 2010-05 ,pp. : 272-282

Bentham Science Publishers

Access to resources Recommend Favorite

Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 28-42

Bentham Science Publishers

Access to resources Recommend Favorite

Paclitaxel and Platinum Chemotherapy for Ovarian Carcinoma during Pregnancy

By Sood A.K. Shahin M.S. Sorosky J.I.

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 599-600

Elsevier

Access to resources Recommend Favorite

Platinum Compounds: A Hope for Future Cancer Chemotherapy

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 2, 2013-02 ,pp. : 296-306

Bentham Science Publishers

Access to resources Recommend Favorite

Markers of response to platinum-based chemotherapy in lung cancer

By Barr Martin P MacDonagh Lauren O'Byrne Kenneth J

Lung Cancer Management, Vol. 2, Iss. 3, 2013-06 ,pp. : 227-239

Future Medicine

Access to resources Recommend Favorite